EP 54: 5 Trials that will change your practice: Review of ESC 21 with Dr Purvi Parwani
b'In this week\\u2019s episode Dr Ankur Kalra\\u2019s guest is Dr. Purvi Parwani, Director of Women\\u2019s Cardiovascular Disease Clinic and Assistant Professor at Loma Linda University Medical Center.\\nIn this special ESC 2021 edition of Parallax, Ankur asks Purvi to review the highlights of the congress. Purvi summarises the design and findings of the trials and their importance in the treatment of patients. Ankur and Purvi discuss how the novel data presented at ESC will inform their practice.\\n \\nTrials covered in detail include\\n\\u2022 SSaSS: Effect of Salt Substitution on Cardiovascular Events and Death,\\n\\u2022 STEP: Intensive vs. standard blood pressure control among older hypertensive patients\\n\\u2022 EMPEROR-Preserved and Pooled: Effect of empagliflozin on cardiovascular death and heart failure hospitalisations in patients with heart failure with a preserved ejection fraction, with and without diabetes,\\n\\u2022 LOOP: Screening for AF with an implantable loop recorder to prevent stroke compared with results of the STROKESTOP trial,\\n\\u2022 IAMI: Influenza Vaccination after Myocardial Infarction randomised trial.\\n \\nWhat are the take-home messages of ESC 21? How can we utilise the findings in our practice? What are the questions that need further investigation?\\n\\nQuestions and comments can be sent to \\u201cpodcast@radcliffe-group.com\\u201d and may be answered by Ankur in the next episode. Guest @purviparwani, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.\\n\\nBrought to you by Edwards: www.edwardstavr.com'